WO2008143182A1 - 甘草ポリフェノールを含有する組成物 - Google Patents

甘草ポリフェノールを含有する組成物 Download PDF

Info

Publication number
WO2008143182A1
WO2008143182A1 PCT/JP2008/059062 JP2008059062W WO2008143182A1 WO 2008143182 A1 WO2008143182 A1 WO 2008143182A1 JP 2008059062 W JP2008059062 W JP 2008059062W WO 2008143182 A1 WO2008143182 A1 WO 2008143182A1
Authority
WO
WIPO (PCT)
Prior art keywords
food
licorice
derived polyphenol
polyphenol
composition
Prior art date
Application number
PCT/JP2008/059062
Other languages
English (en)
French (fr)
Inventor
Hirokazu Sakamoto
Yuji Tominaga
Shiro Kitamura
Shinichi Yokota
Original Assignee
Kaneka Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corporation filed Critical Kaneka Corporation
Priority to JP2009515212A priority Critical patent/JPWO2008143182A1/ja
Priority to EP08752895A priority patent/EP2163252A4/en
Publication of WO2008143182A1 publication Critical patent/WO2008143182A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

　甘草ポリフェノールとそれ以外の有効成分（抗酸化成分、甘草ポリフェノール以外のポリフェノールまたは脂質の吸収もしくは代謝にかかわる成分）を含有する組成物は、安全性が高く容易に製造することができ、健康食品や保健機能食品（特定保健用食品、栄養機能食品）などの飲食品、または医薬品、医薬部外品、化粧品などに利用することができる。また該組成物は、体脂肪蓄積抑制、体脂肪分解促進またはエネルギー産生促進効果を有し、肥満やメタボリックシンドローム等の治療に有用である。
PCT/JP2008/059062 2007-05-17 2008-05-16 甘草ポリフェノールを含有する組成物 WO2008143182A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009515212A JPWO2008143182A1 (ja) 2007-05-17 2008-05-16 甘草ポリフェノールを含有する組成物
EP08752895A EP2163252A4 (en) 2007-05-17 2008-05-16 COMPOSITION CONTAINING A POLYPHENOL DERIVED FROM THE LICENSE

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007131779 2007-05-17
JP2007-131779 2007-05-17
US95043207P 2007-07-18 2007-07-18
US60/950,432 2007-07-18

Publications (1)

Publication Number Publication Date
WO2008143182A1 true WO2008143182A1 (ja) 2008-11-27

Family

ID=40027715

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/059062 WO2008143182A1 (ja) 2007-05-17 2008-05-16 甘草ポリフェノールを含有する組成物

Country Status (4)

Country Link
US (1) US20080286254A1 (ja)
EP (1) EP2163252A4 (ja)
JP (1) JPWO2008143182A1 (ja)
WO (1) WO2008143182A1 (ja)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010074220A1 (ja) * 2008-12-26 2010-07-01 サントリーホールディングス株式会社 セサミン類とエピガロカテキンガレートとを含有する組成物
WO2011042958A1 (ja) * 2009-10-06 2011-04-14 森永製菓株式会社 ポリフェノール類化合物の吸収促進剤及びその利用
WO2011148657A1 (ja) * 2010-05-24 2011-12-01 ハウスウェルネスフーズ株式会社 メタボリックシンドロームの予防、改善または治療用組成物
JP2013537890A (ja) * 2010-09-10 2013-10-07 コリア フード リサーチ インスティチュート ハリグワ及びヨクイニンを含む肥満抑制又は血糖降下用組成物、並びにその用途
JP2014025039A (ja) * 2012-07-30 2014-02-06 Riken Vitamin Co Ltd 食品用油溶性色素製剤
CN104348411A (zh) * 2013-07-23 2015-02-11 Ls产电株式会社 用于太阳能电池组件的温控系统
JP2015047115A (ja) * 2013-08-30 2015-03-16 サントリー食品インターナショナル株式会社 烏龍茶抽出物を含有する容器詰飲料
JP2015508748A (ja) * 2012-01-30 2015-03-23 ユリエヴィッチ レシコフ，セルゲイ ヒト及び動物細胞において熱ショックタンパク質の合成を誘導する剤；修復過程を促進するための化粧品；侵襲的美容処置の副作用を低減するための化粧品；栄養補助食品；食料品；侵襲的美容処置の副作用を低減する方法
WO2016129611A1 (ja) * 2015-02-09 2016-08-18 フードテック・トレーディング株式会社 抗酸化剤組成物およびそれを添加した油脂
KR20160121534A (ko) * 2014-01-16 2016-10-19 인큐팜 그룹 센디리안 버하드 식이 지방 흡수를 감소시키는데 사용하기 위한 오크라를 포함하는 조성물
WO2017094892A1 (ja) * 2015-12-03 2017-06-08 エムジーファーマ株式会社 健康肥満維持剤
WO2018131643A1 (ja) * 2017-01-12 2018-07-19 三菱瓦斯化学株式会社 ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル
JP2019131527A (ja) * 2018-02-02 2019-08-08 富士化学工業株式会社 腸内細菌叢中のアッカーマンシアを増やすためにアスタキサンチンを使用する方法及び医薬組成物
JP2019147824A (ja) * 2019-05-14 2019-09-05 株式会社東洋新薬 黒生姜含有組成物
WO2022030443A1 (ja) * 2020-08-07 2022-02-10 キッコーマン株式会社 飲食品
JP7224008B1 (ja) 2022-08-30 2023-02-17 株式会社東洋新薬 経口組成物
JP2023120103A (ja) * 2022-02-17 2023-08-29 エムジーファーマ株式会社 脂肪分解促進剤

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117608A1 (en) * 2004-06-04 2005-12-15 Horizon Science Pty Ltd Natural sweetener
WO2006128259A1 (en) 2005-06-03 2006-12-07 Horizon Science Pty Ltd Substances having body mass redistribution properties
CN101553582A (zh) * 2006-09-19 2009-10-07 视界科技有限公司 从甘蔗中获得的提取物及其生产方法
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
FR2939045B1 (fr) * 2008-12-02 2010-12-31 Daniel Sincholle Compositions pharmaceutiques et nutritionnelles et methode utile pour prevenir et traiter l'inflammation colique et l'endotoxemie metabolique
KR101078376B1 (ko) * 2009-02-02 2011-10-31 연세대학교 산학협력단 피페린 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 예방 및 치료용 조성물
US20100323031A1 (en) * 2009-06-22 2010-12-23 Glykon Technologies Group, Llc Synergistic combination to enhance blood glucose and insulin metabolism
DK2459203T3 (en) 2009-07-30 2019-02-18 Dupont Nutrition Biosci Aps Lactic Acid Bacteria and Bifidobacteria for the Treatment of Endotoxemia
JP5620660B2 (ja) * 2009-09-03 2014-11-05 学校法人近畿大学 脂肪代謝改善剤、該脂肪代謝改善剤を含有する医薬及び食品、並びに新規フラボノイド化合物
US8642088B2 (en) * 2009-09-04 2014-02-04 Wisconsin Alumni Research Foundation Tannin-chitosan composites
DE102010028365A1 (de) * 2010-04-29 2011-11-03 Lichtblick Gmbh Verwendung einer Phospholipid enthaltenden Zusammensetzung zur Entfernung von subkutanen Fettansammlungen
CN101984840B (zh) * 2010-08-18 2012-08-29 湖南普菲克生物科技有限公司 猪用多元机体抗氧化剂及其制备方法
CN101926431A (zh) * 2010-08-23 2010-12-29 贵阳高新创嘉创业服务有限公司 一种具有保健功能的组合物及其制备方法和用途
US8614184B2 (en) * 2010-09-22 2013-12-24 Ronald P. Santasiero HCG formulations for achieving weight loss
CN102020779B (zh) * 2010-11-17 2012-08-22 河南工业大学 一种可食抗菌包装膜的制备方法
US9340477B2 (en) * 2010-11-26 2016-05-17 Uha Mikakuto Co., Ltd. Process for production of hydroxystilbene derivative having physiological activity
EP2672832B1 (en) 2011-02-08 2020-03-25 The Product Makers (Australia) Pty Ltd Sugar extracts
ITRM20110161A1 (it) * 2011-03-29 2012-09-30 Lo Li Pharma Srl Formulazione integrativa finalizzata alla gestione dei disturbi dovuti alle carenze ormonali tipiche delle donne in climaterio ed in menopausa
BR112014000895A2 (pt) 2011-07-15 2019-08-06 Nusirt Sciences Inc composições e métodos para modular rotas metabólicas
CN102356879B (zh) * 2011-10-21 2014-08-06 深圳市俪斯生物科技有限公司 一种功能肽强化的保健食品
WO2013109488A1 (en) * 2012-01-16 2013-07-25 Glaxosmithkline Intellectual Property (No.2) Limited Compositions and methods for treating diabetes and/or obesity
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
WO2013173719A1 (en) * 2012-05-18 2013-11-21 Metaproteomics, Llc Phytonutrient compositions and methods of use
CN102813208B (zh) * 2012-07-10 2014-04-16 陈道亮 预防肺癌的饮食补充剂及其制备方法
AU2013308395C1 (en) 2012-08-28 2018-03-15 Poly Gain Pte Ltd Extraction method
US9943517B2 (en) 2012-11-13 2018-04-17 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
US9517249B2 (en) 2012-11-26 2016-12-13 Access Business Group International Llc Antioxidant dietary supplement and related method
JP6550370B2 (ja) 2013-03-15 2019-07-24 ニューサート サイエンシーズ， インコーポレイテッド 脂質レベルを低下させるロイシンおよびニコチン酸
CN103285110B (zh) * 2013-05-10 2015-03-18 西北农林科技大学 一种治疗高血脂症的中药及其制备方法
WO2015006646A1 (en) * 2013-07-11 2015-01-15 Specialty Nutrition Group, Inc. Compositions comprising hydroxytyrosol, curcumin, and/or astaxanthin and use thereof
EP3035949B1 (en) 2013-08-16 2023-10-04 Poly Gain Pte Ltd Sugar cane derived extracts and uses
CN103478850B (zh) * 2013-09-26 2014-11-26 天津市益倍建生物技术有限公司 一种含有白藜芦醇、具有降血糖作用的组合物及含其固体饮料
WO2015071373A1 (en) * 2013-11-13 2015-05-21 Ceva Sante Animale Formulations comprising s-adenosyl-methionine, quercetin and glycyrrhizin for liver health
CA2939833A1 (en) 2014-02-27 2015-09-03 Nusirt Sciences, Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
CN103907753B (zh) * 2014-03-13 2015-04-29 浙江大学 一种植物源活性饲料添加剂及应用
WO2015173705A1 (en) * 2014-05-15 2015-11-19 Pesle Livio Decoction of olive leaves
CN104055773B (zh) * 2014-07-03 2016-05-25 万红贵 一种降血脂组合物及其应用
US20170368018A1 (en) * 2014-12-19 2017-12-28 Halo Life Science, Llc Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
US10285963B2 (en) * 2015-06-08 2019-05-14 Horacio Astudillo de la Vega Combination of metabolic bio-energetic and nutra-epigentic regulators, nutraceutical compounds in conventional and nanotechnologies combination to revert and prevent the chronic damage accelerated cellular senescence produced by diabetes and other degenerative chronic complex diseases
WO2017213486A2 (es) * 2016-06-08 2017-12-14 Astudillo De La Vega Horacio Combinación de reguladores metabólicos bioenergéticos y nutra-epigenéticos, compuestos nutracéuticos en combinaciónes convencionales y nanotecnológicas para revertir y prevenir la sesencencia celular acelerada por daño crónico producida por diabetes y otras enfermedades complejas crónico-degenerativas
CN106543260B (zh) * 2015-10-19 2018-01-05 陕西中医药大学 一种甘草酸的生物提取方法
CN108882743B (zh) * 2016-03-29 2022-11-11 捷通国际有限公司 用于激活受试者的抗氧化系统的营养补充剂及相关方法
ITUA20162588A1 (it) * 2016-04-14 2017-10-14 Difass Int S R L Uso di una composizione comprendente acido alfa-lipoico.
CN106901160B (zh) * 2017-03-14 2020-09-11 广州好孝心营养健康研究有限公司 降糖、减肥、保护糖尿病器官的食品添加粉及其制备方法和用途
CN107594265A (zh) * 2017-11-01 2018-01-19 黄业钧 一种具有保健功能的减肥饮料及其制备方法
CN108314160A (zh) * 2018-01-12 2018-07-24 中山大学 偶氮染料的原位脱色方法及其应用
FR3090008B1 (fr) * 2018-12-17 2023-03-31 Pennakem Europa Procédé de production d'une huile brute riche en polyphénol par extraction solide/liquide
CN109700813A (zh) * 2019-02-28 2019-05-03 张�成 一种组合物及其应用
ES2804649B2 (es) * 2019-08-06 2021-07-20 Univ Rovira I Virgili Composición hipoleptinémica y su uso
IT202100006713A1 (it) * 2021-03-19 2022-09-19 Gabriele CAPPELLINO Composizione di olio vegetale commestibile e suoi impieghi
CN113143962B (zh) * 2021-05-11 2022-08-05 四川九章生物科技有限公司 一种治疗高脂血症的药物组合物及其制备方法
WO2023282783A1 (ru) * 2021-07-09 2023-01-12 Акционерное Общество "Акванова Рус" Мицеллированный раствор активного компонента на основе экстракта лакрицы, способ его получения и применения
CN114605242A (zh) * 2022-04-11 2022-06-10 澳门大学 间苯三酚类化合物的制备方法与药物、保健产品和食品

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047699A1 (fr) 2000-12-12 2002-06-20 Kaneka Corporation Compositions de prévention ou d'amélioration de syndromes multifactoriels
JP2003081744A (ja) * 2001-09-14 2003-03-19 Maruzen Pharmaceut Co Ltd 抗酸化剤
WO2003037316A1 (fr) 2001-10-11 2003-05-08 Kaneka Corporation Ligands de recepteurs actives par le proliferateur de peroxisome et procede de fabrication correspondant
WO2004041257A2 (en) * 2002-11-07 2004-05-21 Dsm Ip Assets B.V. Novel nutraceutical compositions comprising epigallocatechin gallate
JP2004339141A (ja) * 2003-05-15 2004-12-02 Kanebo Ltd 皮膚化粧料
WO2005011672A1 (ja) * 2003-07-31 2005-02-10 Kaneka Corporation 生活習慣病予防・改善用の油脂加工組成物
WO2005110400A1 (ja) 2004-05-13 2005-11-24 Kaneka Corporation リパーゼ阻害剤、コレステロールエステラーゼ阻害剤、中性脂肪吸収抑制剤、コレステロール吸収抑制剤及びコレステロールエステル吸収抑制剤
WO2006085562A1 (ja) 2005-02-09 2006-08-17 Kaneka Corporation メタボリックシンドローム及びインスリン抵抗性症候群の予防及び／又は処置用組成物
JP2006212021A (ja) * 2005-08-05 2006-08-17 Ajinomoto Co Inc 食品組成物
JP2006265140A (ja) * 2005-03-23 2006-10-05 Shiseido Co Ltd 美白剤、美白用皮膚外用剤および美白方法
WO2006103750A1 (ja) * 2005-03-29 2006-10-05 Nippon Meat Packers, Inc. 肥満改善用組成物、機能性食品及び医薬用組成物
WO2007060992A1 (ja) 2005-11-25 2007-05-31 Kaneka Corporation メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3763075B2 (ja) * 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
DE60328002D1 (de) * 2002-04-04 2009-07-30 Kaneka Corp Verfahren zur herstellung einer fettzusammensetzung mit hydrophoben komponenten von glycyrrhiza

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047699A1 (fr) 2000-12-12 2002-06-20 Kaneka Corporation Compositions de prévention ou d'amélioration de syndromes multifactoriels
JP2003081744A (ja) * 2001-09-14 2003-03-19 Maruzen Pharmaceut Co Ltd 抗酸化剤
WO2003037316A1 (fr) 2001-10-11 2003-05-08 Kaneka Corporation Ligands de recepteurs actives par le proliferateur de peroxisome et procede de fabrication correspondant
WO2004041257A2 (en) * 2002-11-07 2004-05-21 Dsm Ip Assets B.V. Novel nutraceutical compositions comprising epigallocatechin gallate
JP2004339141A (ja) * 2003-05-15 2004-12-02 Kanebo Ltd 皮膚化粧料
WO2005011672A1 (ja) * 2003-07-31 2005-02-10 Kaneka Corporation 生活習慣病予防・改善用の油脂加工組成物
WO2005110400A1 (ja) 2004-05-13 2005-11-24 Kaneka Corporation リパーゼ阻害剤、コレステロールエステラーゼ阻害剤、中性脂肪吸収抑制剤、コレステロール吸収抑制剤及びコレステロールエステル吸収抑制剤
WO2006085562A1 (ja) 2005-02-09 2006-08-17 Kaneka Corporation メタボリックシンドローム及びインスリン抵抗性症候群の予防及び／又は処置用組成物
JP2006265140A (ja) * 2005-03-23 2006-10-05 Shiseido Co Ltd 美白剤、美白用皮膚外用剤および美白方法
WO2006103750A1 (ja) * 2005-03-29 2006-10-05 Nippon Meat Packers, Inc. 肥満改善用組成物、機能性食品及び医薬用組成物
JP2006212021A (ja) * 2005-08-05 2006-08-17 Ajinomoto Co Inc 食品組成物
WO2007060992A1 (ja) 2005-11-25 2007-05-31 Kaneka Corporation メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AOE S. ET AL.: "KK Mouse no Naizo Shibo Chikuseki ni Oyobosu Shokuhin Sozai no Eikyo", THE JAPANESE SOCIETY OF NUTRITION AND FOOD SCIENCE TAIKAI KOEN YOSHISHU, vol. 60TH, 2006, pages 65 *
AOKI F. ET AL.: "Suppression by Licorice Flavonoids of Abdominal Fat Accumulation and Body Weight Gain in High-Fat Diet-Induced Obese C57BL/6J Mice", BIOSCI. BIOTECHNOL. BIOCHEM., vol. 71, no. 1, January 2007 (2007-01-01), pages 206 - 214, XP002538766 *
CHEMISTRY OF ORGANIC NATURAL PRODUCTS, vol. 73, 1998
HAMANO Y.: "Effects of dietary lipoic acid on plasma lipid, in vitro insulin sensitivity, metabolic response to corticosterone and in vitro lipolysis in broiler chickens", BR. J. NUTR., vol. 95, no. 6, 2006, pages 1094 - 1101, XP008125008 *
NAKAGAWA K. ET AL.: "Licorice Flavonoids Suppress Abdominal Fat Accumulation and Increase in Blood Glucose Level in Obese Diabetic KK-Ay Mice", BIOL. PHARM. BULL., vol. 27, no. 11, 2004, pages 1775 - 1778, XP008125009 *
See also references of EP2163252A1
SHIMODA H. ET AL.: "Coenzyme Q10, alpha-lipolic acid no Koka o Saguru alpha-lipolic acid no Diet Koka", FRAGR. J., vol. 33, no. 8, 2005, pages 63 - 67, XP008125007 *
YOGU S. ET AL.: "alpha-lipolic acid no Hakushoku Shibo Saibo 3T3-L1 ni Okeru Shibo Chikuseki eno Eikyo", NIPPON NOGEI KAGAKUKAI TAIKAI KOEN YOSHISHU, vol. 2006, 2006, pages 71, XP008118287 *

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010074220A1 (ja) * 2008-12-26 2010-07-01 サントリーホールディングス株式会社 セサミン類とエピガロカテキンガレートとを含有する組成物
WO2011042958A1 (ja) * 2009-10-06 2011-04-14 森永製菓株式会社 ポリフェノール類化合物の吸収促進剤及びその利用
JPWO2011042958A1 (ja) * 2009-10-06 2013-02-28 森永製菓株式会社 ポリフェノール類化合物の吸収促進剤及びその利用
WO2011148657A1 (ja) * 2010-05-24 2011-12-01 ハウスウェルネスフーズ株式会社 メタボリックシンドロームの予防、改善または治療用組成物
KR101490730B1 (ko) * 2010-05-24 2015-02-06 하우스 웰니스 푸드 코퍼레이션 대사 증후군의 예방, 개선 또는 치료용 조성물
US9993493B2 (en) 2010-05-24 2018-06-12 House Wellness Foods Corporation Composition for prevention, amelioration or treatment of metabolic syndrome
JP2013537890A (ja) * 2010-09-10 2013-10-07 コリア フード リサーチ インスティチュート ハリグワ及びヨクイニンを含む肥満抑制又は血糖降下用組成物、並びにその用途
JP2015508748A (ja) * 2012-01-30 2015-03-23 ユリエヴィッチ レシコフ，セルゲイ ヒト及び動物細胞において熱ショックタンパク質の合成を誘導する剤；修復過程を促進するための化粧品；侵襲的美容処置の副作用を低減するための化粧品；栄養補助食品；食料品；侵襲的美容処置の副作用を低減する方法
JP2014025039A (ja) * 2012-07-30 2014-02-06 Riken Vitamin Co Ltd 食品用油溶性色素製剤
US9847440B2 (en) 2013-07-23 2017-12-19 Lsis Co., Ltd. Temperature control system for solar cell module
CN104348411A (zh) * 2013-07-23 2015-02-11 Ls产电株式会社 用于太阳能电池组件的温控系统
JP2015047115A (ja) * 2013-08-30 2015-03-16 サントリー食品インターナショナル株式会社 烏龍茶抽出物を含有する容器詰飲料
KR20160121534A (ko) * 2014-01-16 2016-10-19 인큐팜 그룹 센디리안 버하드 식이 지방 흡수를 감소시키는데 사용하기 위한 오크라를 포함하는 조성물
JP2017507920A (ja) * 2014-01-16 2017-03-23 インキューファーム グループ エスディーエヌ ビーエイチディー 食事性脂肪吸収の低下における使用のためのオクラを含む組成物
KR102384233B1 (ko) * 2014-01-16 2022-04-06 넥시라 에스아에스 식이 지방 흡수를 감소시키는데 사용하기 위한 오크라를 포함하는 조성물
WO2016129611A1 (ja) * 2015-02-09 2016-08-18 フードテック・トレーディング株式会社 抗酸化剤組成物およびそれを添加した油脂
WO2017094892A1 (ja) * 2015-12-03 2017-06-08 エムジーファーマ株式会社 健康肥満維持剤
JPWO2018131643A1 (ja) * 2017-01-12 2019-11-07 三菱瓦斯化学株式会社 ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル
CN110177471A (zh) * 2017-01-12 2019-08-27 三菱瓦斯化学株式会社 含有吡咯喹啉醌或其盐及支链氨基酸的胶囊
EP3569070A4 (en) * 2017-01-12 2020-10-07 Mitsubishi Gas Chemical Company, Inc. CAPSULES WITH PYRROLOCHINOLINCHINONE OR SALT THEREOF AND BRANCHED CHAIN AMINO ACID
WO2018131643A1 (ja) * 2017-01-12 2018-07-19 三菱瓦斯化学株式会社 ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル
JP7069531B2 (ja) 2017-01-12 2022-05-18 三菱瓦斯化学株式会社 ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル
JP2019131527A (ja) * 2018-02-02 2019-08-08 富士化学工業株式会社 腸内細菌叢中のアッカーマンシアを増やすためにアスタキサンチンを使用する方法及び医薬組成物
JP2022043349A (ja) * 2018-02-02 2022-03-15 富士化学工業株式会社 腸内細菌叢中のアッカーマンシアを増やすためにアスタキサンチンを使用する方法及び医薬組成物
JP2019147824A (ja) * 2019-05-14 2019-09-05 株式会社東洋新薬 黒生姜含有組成物
WO2022030443A1 (ja) * 2020-08-07 2022-02-10 キッコーマン株式会社 飲食品
JP2023120103A (ja) * 2022-02-17 2023-08-29 エムジーファーマ株式会社 脂肪分解促進剤
JP7445689B2 (ja) 2022-02-17 2024-03-07 エムジーファーマ株式会社 脂肪分解促進剤
JP7224008B1 (ja) 2022-08-30 2023-02-17 株式会社東洋新薬 経口組成物
JP2024033053A (ja) * 2022-08-30 2024-03-13 株式会社東洋新薬 経口組成物

Also Published As

Publication number Publication date
US20080286254A1 (en) 2008-11-20
EP2163252A4 (en) 2012-01-11
EP2163252A1 (en) 2010-03-17
JPWO2008143182A1 (ja) 2010-08-05

Similar Documents

Publication Publication Date Title
WO2008143182A1 (ja) 甘草ポリフェノールを含有する組成物
EP1920774A4 (en) COMPOSITION CONTAINING FUCOIDAN OR FUCOIDAN HYDROLYSAT AND AN IMMUNOSTIMULATING SUBSTANCE
PH12013501791B1 (en) Uses of dpp-iv inhibitors
MY148723A (en) Use of pinolenic acid for the treatment of obesity
MX356491B (es) Uso de un inhibidor de sglt2 en combinación con una insulina para tratar, prevenir o reducir el riesgo de hipoglucemia.
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
EP2074985A3 (en) Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof
MX2012002343A (es) Agente contra la obesidad, alimento o bebida contra la obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa.
BRPI0513466A (pt) antivìrus natural e composição compreendendo o mesmo
EP2241196A3 (en) Nutritional supplement comprising oligosaccharides and cysteine for treating hiv
WO2008129980A1 (ja) 還元型補酵素ｑ１０含有粒子状組成物及びその製造方法
IL154318A0 (en) Pharmaceutical compositions for the treatment of movement disorders
WO2006012213A3 (en) Composition and method for delivery of phytochemicals
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
WO2018169282A3 (ko) Atpif1을 함유하는 당뇨 치료용 약학조성물
WO2018093238A3 (ko) 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
WO2008105113A1 (ja) 口腔内用殺菌剤、及び該殺菌剤を含有する食品添加剤
WO2011163319A3 (en) Activation of amp-protein activated kinase by oxaloacetate compounds
WO2008046865A3 (en) Long-term feed - elderly
GB2456475A (en) Composition for the treatment of skin conditions
MX2013004371A (es) Cisteina y consumo de alimentos.
WO2008123128A1 (ja) アディポネクチン産生促進剤
WO2007142984A3 (en) Nutritional formulations and associated methods
WO2011019174A3 (ko) 항산화 및 미백 효능을 갖는 막걸리 농축액 함유 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08752895

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009515212

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008752895

Country of ref document: EP